Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Lung Cancer
Related studies linked through entity extraction aliases.
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
- Status
- RECRUITING
- Phase
- N/A
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
TIL Therapy for Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.
- Status
- UNKNOWN
- Phase
- NA
Study of JS004 Combined With Toripalimab for Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Exercise, Nutrition, and Palliative Care in Advanced Lung Cancer (ENPAL)
- Status
- COMPLETED
- Phase
- NA
Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator
- Status
- COMPLETED
- Phase
- N/A
Descriptors and Predictors of Burden and Information Needs
- Status
- COMPLETED
- Phase
- N/A
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2